Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jcv.2020.104583 http://scihub22266oqcxt.onion/10.1016/j.jcv.2020.104583 32791382!7413157!32791382     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Clin+Virol 2020 ; 130 (ä): 104583 Nephropedia Template TP {{tp|p=32791382|t=2020. Multicenter evaluation of the NeuMoDx SARS-CoV-2 Test |pdf=|usr=}}{{32791382}} gab.com Text Multicenter evaluation of the NeuMoDx SARS-CoV-2 Test JO: J Clin Virol http://www.kidney.de/pget.php?&tw=1&pmid=32791382 #FOAvip The SARS-CoV-2 virus has caused millions of confirmed COVID-19 cases worldwide and hundreds of thousands of deaths in less than 6 months. Mitigation measures including social distancing were implemented to control disease spread, however, thousands of new cases continue to be diagnosed daily. To resume some suspended social activities, early diagnosis and contact tracing are essential. To meet this required diagnostic and screening capacity, high throughput diagnostic assays are needed. The NeuMoDx SARS-CoV-2 assay, performed on a NeuMoDx molecular system, is a rapid, fully automated, qualitative real-time RT-PCR diagnostic test with throughput of up to 288 tests in an 8?-h shift. The assay received emergency use authorization from the FDA and is used in some large testing centers in the US. This paper describes the analytical and clinical performance of the assay at three centers: Johns Hopkins Hospital, St. Jude Children's Research Hospital, and the Wadsworth Center. Twit Text FOAVip Multicenter evaluation of the NeuMoDx SARS-CoV-2 Test ????J Clin Virol http://www.kidney.de/pget.php?&tw=1&pmid=32791382 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32791382 #FOAvip English Wikipedia <ref>{{Cite pmid|32791382}}</ref> Multicenter evaluation of the NeuMoDx SARS-CoV-2 Test #MMPMID32791382 Mostafa HH; Lamson DM; Uhteg K; Geahr M; Gluck L; de Cardenas JNB; Morehead E; Forman M; Carroll KC; Hayden RT; George KS J Clin Virol 2020[Sep]; 130 (ä): 104583 PMID32791382show ga The SARS-CoV-2 virus has caused millions of confirmed COVID-19 cases worldwide and hundreds of thousands of deaths in less than 6 months. Mitigation measures including social distancing were implemented to control disease spread, however, thousands of new cases continue to be diagnosed daily. To resume some suspended social activities, early diagnosis and contact tracing are essential. To meet this required diagnostic and screening capacity, high throughput diagnostic assays are needed. The NeuMoDx SARS-CoV-2 assay, performed on a NeuMoDx molecular system, is a rapid, fully automated, qualitative real-time RT-PCR diagnostic test with throughput of up to 288 tests in an 8?-h shift. The assay received emergency use authorization from the FDA and is used in some large testing centers in the US. This paper describes the analytical and clinical performance of the assay at three centers: Johns Hopkins Hospital, St. Jude Children's Research Hospital, and the Wadsworth Center. |Automation, Laboratory[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Testing[MESH] |COVID-19 Vaccines[MESH] |Clinical Laboratory Techniques/*methods[MESH] |Coronavirus Infections/*diagnosis/virology[MESH] |High-Throughput Screening Assays/*methods[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/*diagnosis/virology[MESH] |SARS-CoV-2[MESH] |Sensitivity and Specificity[MESH]Multicenter evaluation of the NeuMoDx SARS-CoV-2 Test (epmc).pdf DeepDyve Pubget Overpricing